Related Experiment Video
Updated: Jun 30, 2026
10:36
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Estrogen signaling pathway and hormonal therapy
Shin-ichi Hayashi1, Yuri Yamaguchi
1Department of Molecular and Functional Dynamics, Laboratory Medicine and Sciences, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai 980-8575, Japan. shayashi@mail.tains.tohoku.ac.jp
Breast Cancer (Tokyo, Japan)
|September 27, 2008
Summary
Hormonal therapies show variable efficacy due to complex estrogen signaling in breast cancer. Understanding these pathways is key to predicting treatment response and developing new strategies for endocrine resistance.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Hormonal therapies, including luteinizing hormone-releasing hormone (LH-RH) agonists, selective estrogen receptor modulators (SERMs), and aromatase inhibitors, are advancing for cancer treatment.
- Current biomarkers like estrogen receptor (ER) and progesterone receptor (PgR) have limitations in predicting individual response to endocrine therapy.
- Discrepancies in treatment outcomes, such as resistance to aromatase inhibitors, suggest underlying molecular mechanisms beyond ER status.
Purpose of the Study:
- To explore the molecular mechanisms driving differential responses to hormonal therapies in breast cancer.
- To investigate the role of estrogen-related intracellular signaling pathways in treatment efficacy and resistance.
- To discuss current and future strategies for predicting individual hormonal therapy effectiveness.
Main Methods:
- Review of current literature on hormonal therapies and breast cancer signaling pathways.
- Analysis of molecular mechanisms underlying variable patient responses to endocrine treatments.
- Discussion of predictive biomarkers and novel therapeutic strategies.
Main Results:
- Estrogen receptor alpha (ERalpha)-positive patients exhibit variable responses to endocrine therapy, with approximately one-third not responding.
- Some ERalpha-negative patients paradoxically respond to endocrine therapy.
- Intracellular estrogen signaling pathways and mechanisms of aromatase inhibitor resistance contribute to treatment ineffectiveness.
Conclusions:
- Individual efficacy of hormonal therapy is influenced by complex intracellular estrogen signaling pathways, not solely ER status.
- Understanding these pathways is crucial for overcoming endocrine resistance and improving treatment outcomes.
- Further research into molecular mechanisms will enable better prediction of hormonal therapy efficacy and development of personalized treatment strategies.
Related Concept Videos
01:08Chemical Signaling in the Endocrine System
A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
01:45Endocrine Signaling
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
01:45Endocrine Signaling
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
01:22Target Cell Response to Hormones
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
01:26Signal Transduction: Overview
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.